Latest News

September 30, 2013
Three Gladstone scientists have won research awards from divisions of the National Institutes of Health equaling an approximate total of $12.5 million over five years for their groundbreaking research to overcome HIV/AIDS.
July 10, 2013
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
June 25, 2013
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
May 13, 2013
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
March 05, 2013
Community intervention with free mobile HIV testing and counseling, same-day results and post-test support led to a 14 percent reduction in new HIV infections in targeted communities in Sub-Saharan Africa, according to results of a large randomized, controlled trial.
October 16, 2012
The National Institutes of Health has awarded more than $15 million over the next five years to the UCSF-Gladstone Center for AIDS Research (CFAR) to continue its pioneering translational AIDS research.
October 02, 2012
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
September 14, 2012
Scientists at the UCSF-affiliated Gladstone Institutes have devised a method to track HIV inside individual cells — an important development for understanding “HIV latency" when the virus goes dormant after the patient begins antiretroviral treatment.
September 12, 2012
New research from an international team of HIV/AIDS experts has reaffirmed the effectiveness of Truvada — the first and only medication approved by the FDA for HIV prevention.
August 22, 2012
UCSF researchers found that poor HIV-infected individuals living in San Francisco are significantly more likely to visit emergency rooms and to have hospital stays if they lack access to food of sufficient quality and quantity for a healthy life.

Pages